Kew, Y., Salomon, H., Olsen, L. R., Wainberg, M. A., & Prasad, V. R. (1996). The nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitors.

Kew, Y., H. Salomon, L R. Olsen, M A. Wainberg, and V R. Prasad. The Nucleoside Analog-resistant E89G Mutant of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Displays a Broader Cross-resistance That Extends to Nonnucleoside Inhibitors. 1996.

Kew, Y., et al. The Nucleoside Analog-resistant E89G Mutant of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Displays a Broader Cross-resistance That Extends to Nonnucleoside Inhibitors. 1996.